Home / Case Studies

From nanoscale science to registered, market-ready products.

Four programmes across four countries — spanning medical devices, metabolic health, and green-nanotechnology consumer products.

ScavMedical Ltd.

YOUFILTER Ag® — silver-nanoparticle respiratory filter

Sector
Medical device · respiratory protection
Markets
Brazil & United States
Technology
Green-synthesis AgNPs · electrostatic HMEF
Regulatory
ANVISA reg. 81484769004
Partner
IPEN (Nuclear & Energy Research Institute)

Challenge

ScavMedical had a compelling green-nanotechnology concept — a silver-nanoparticle respiratory filter — but needed to prove antimicrobial performance and safety to a regulator’s standard, and to translate laboratory results into a registrable, manufacturable medical device.

Approach

  • Guided the science behind the YOUFILTER Ag® HMEF and Youshield Ag® electrostatic membrane, embedding AgNPs produced by a proprietary green-synthesis platform.
  • Structured the evidence package for antimicrobial efficacy, biocompatibility, and nanoparticle-leaching safety.
  • Coordinated collaboration with IPEN and aligned the dossier to ANVISA requirements for market registration.

Result

  • Achieved 99.999% bacterial and viral filtration efficiency (BFE/VFE) with broad-spectrum antimicrobial and antiviral action.
  • Verified nanoparticle leaching held to below 0.1 ppm, supporting the product’s safety profile.
  • Secured ANVISA registration (81484769004) — a registered, commercially available device.
Tecton Ketones

R3HBG bioidentical ketone technology

Sector
Metabolic health · nutraceuticals
Market
United States
Technology
Bioidentical R3HBG ketones
Role
R&D lead & scientific strategy
Origin
“Battlefield science” heritage

Challenge

Tecton set out to bring a bioidentical ketone technology — with roots in military “battlefield science” — into the civilian metabolic-health market, and to build a differentiated, credibly-positioned product portfolio around it.

Approach

  • Led R&D and scientific strategy for the R3HBG bioidentical ketone platform.
  • Shaped a portfolio of functional formulations spanning cognition, energy, and metabolic support.
  • Supported scientific positioning and rebranding to communicate the technology’s rigor to a consumer audience.

Result

  • A differentiated product line including a 12 g R3HBG nootropic for focus and cognition.
  • A 10 g BHB + 5-HTP GLP-1 activator shot targeting metabolic and appetite pathways.
  • A scientifically-anchored brand narrative connecting elite-performance origins to everyday metabolic health.
Kadamba Nano

Green nano-herbal personal care

Sector
Personal care · cosmetics
Market
India
Technology
Green-nanotechnology + phytochemistry
Role
Scientific & commercialization strategy
Portfolio
Face cream · shampoo · serum

Challenge

Translate proprietary green-nanotechnology platforms into a line of natural, bio-compatible personal-care products that could compete commercially while staying true to sustainable, non-toxic principles.

Approach

  • Applied green-synthesis nanotechnology (gold and silver nanoparticles) to phytochemical-rich formulations.
  • Guided product architecture across skincare, haircare, and antioxidant categories.
  • Aligned the science with natural-product positioning for the Indian personal-care market.

Result

  • A commercialized portfolio including Abhaa Gold (gold-nanoparticle face cream), Champo Silver (silver anti-dandruff shampoo), and Yuvani (antioxidant serum).
  • Products built entirely on green-nanotechnology methods — sustainable and bio-compatible by design.
  • A scalable platform approach extensible to further natural-product categories.
Kadamba Africa

Nano-Ayurveda market entry

Sector
Beauty & nutraceuticals
Market
South Africa · Africa
Technology
Nano-Ayurveda · African botanicals
Role
Market-entry & innovation strategy
Founded
2025

Challenge

Adapt a proven Nano-Ayurveda approach for the African market — integrating indigenous botanicals with green nanotechnology — and position it to capture a share of a large, fast-growing beauty and nutraceutical opportunity.

Approach

  • Developed the innovation and market-entry strategy for a Nano-Ayurveda platform tailored to African botanicals such as Rooibos, Marula, and Moringa.
  • Combined traditional botanical knowledge with green-nanotechnology delivery systems.
  • Positioned the venture against a multi-billion-dollar regional market with exclusive botanical sourcing.

Result

  • A launch-ready venture (founded 2025) targeting a US$7B+ beauty and nutraceutical market.
  • A differentiated “Nano-Ayurveda meets African botanicals” positioning with sustainable sourcing.
  • A scalable platform bridging traditional medicine and modern nanoscience.

Your programme could be the next case study.

Whether you are pre-clinical or preparing to scale, the Clementis method brings the same rigor that took these products to market.